Skip to content

Novel Pyridine Derivatives as 5‑HT2A Agonists for Treating Psychiatric Disorders.

Ram W. Sabnis

ACS Medicinal Chemistry Letters May 13, 2025 DOI: 10.1021/acsmedchemlett.5c00244 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed

Abstract

Provided herein are novel pyridine derivatives as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychiatric disorders, and processes for preparing such compounds.